In vitro modeling of blood-brain barrier deregulation by HIV-1 Tat and opioids

被引：0
|
作者：
Maubert, Monique [1 ]
Kercher, Katherine [1 ]
Strazza, Marianne [1 ]
Pirrone, Vanessa [1 ]
Lin, Wei [2 ]
Feng, Rui [2 ]
Wigdahl, Brian [1 ]
Nonnemacher, Michael [1 ]
机构：
[1] Drexel Univ, Coll Med, Inst Mol Med & Infect Dis, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
来源：
JOURNAL OF NEUROVIROLOGY | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P103
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [1] BLOOD-BRAIN BARRIER COMPROMISE BY HIV-1 TAT AND OPIOIDS IN AN IN VITRO MODEL.
    Maubert, M. E.
    Kercher, K. A.
    Strazza, M.
    Pirrone, V
    Lin, W.
    Feng, R.
    Wigdahl, B.
    Nonnemacher, M.
    [J]. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2016, 11 : S30 - S30
  • [2] Tight junction complex deregulation by morphine and HIV-1 Tat exposure in an in vitro blood-brain barrier system
    Maubert, M.
    Kercher, K.
    Strazza, M.
    Pirrone, V
    Lin, W.
    Feng, R.
    Nonnemacher, M.
    [J]. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 : S34 - S34
  • [3] Permeability of the blood-brain barrier to HIV-1 Tat
    Banks, WA
    Robinson, SM
    Nath, A
    [J]. EXPERIMENTAL NEUROLOGY, 2005, 193 (01) : 218 - 227
  • [4] Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function In Vitro
    Patel, Sulay
    Leibrand, Crystal R.
    Palasuberniam, Preetha
    Couraud, Pierre-Olivier
    Weksler, Babette
    Jahr, Fay M.
    McClay, Joseph L.
    Hauser, Kurt F.
    McRae, MaryPeace
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (12)
  • [5] HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity
    Leibrand, Crystal R.
    Paris, Jason J.
    Jones, Austin M.
    Masuda, Quamrun N.
    Halquist, Matthew S.
    Kim, Woong-Ki
    Knapp, Pamela E.
    Kashuba, Angela D. M.
    Hauser, Kurt F.
    McRae, MaryPeace
    [J]. JOURNAL OF NEUROVIROLOGY, 2019, 25 (04) : 560 - 577
  • [6] HIV-1 Tat protein disrupts the blood-brain barrier through the oxidative and inflammatory mechanisms
    Toborek, M
    Pu, H
    Andras, I
    Flora, G
    Lee, YW
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 20 - 20
  • [7] Tight junction regulation by morphine and HIV-1 tat modulates blood-brain barrier permeability
    Mahajan, Supriya D.
    Aalinkeel, Ravikumar
    Sykes, Donald E.
    Reynolds, Jessica L.
    Bindukumar, B.
    Fernandez, Stanley F.
    Chawda, Ramnik
    Shanahan, Thomas C.
    Schwartz, Stanley A.
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2008, 28 (05) : 528 - 541
  • [8] HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood–brain barrier integrity
    Crystal R. Leibrand
    Jason J. Paris
    Austin M. Jones
    Quamrun N. Masuda
    Matthew S. Halquist
    Woong-Ki Kim
    Pamela E. Knapp
    Angela D. M. Kashuba
    Kurt F. Hauser
    MaryPeace McRae
    [J]. Journal of NeuroVirology, 2019, 25 : 560 - 577
  • [9] Breaking down the barrier: The effects of HIV-1 on the blood-brain barrier
    Strazza, Marianne
    Pirrone, Vanessa
    Wigdahl, Brian
    Nonnemacher, Michael R.
    [J]. BRAIN RESEARCH, 2011, 1399 : 96 - 115
  • [10] Effect of HIV-1 Tat-induced senescence on astrocytes and BMECs important for blood-brain barrier
    Marino, Jamie
    Tuzer, Ferit
    Cohen, Justin
    Wigdahl, Brian
    Torres, Claudio
    Nonnemacher, Michael R.
    [J]. JOURNAL OF NEUROVIROLOGY, 2019, 25 (SUPPL 1) : S27 - S27
12345